BOXED WARNING Estrogen plus progestin therapy: increased risk of cardiovascular disorders, breast cancer, and probable dementia; do not use for prevention of cardiovascular disease or dementia.
FDA dosing
Population
Start
Target
Max
Prevention of endometrial hyperplasia (postmenopausal, on estrogen)
Adult
200 mg QHS x12 sequential days per 28-day cycle
Secondary amenorrhea
Adult
400 mg QHS x10 days
Renal Undefined
Hepatic Undefined
Instructions
Take as a single dose at bedtime
If difficulty swallowing, take with a glass of water while standing
Contains peanut oil
Contraindications
Undiagnosed abnormal genital bleeding
Known, suspected, or history of breast cancer
Active or prior deep vein thrombosis / pulmonary embolism
Active or prior arterial thromboembolic disease (stroke, MI)